RNS Number : 4867D
  Hikma Pharmaceuticals Plc
  15 September 2008
   
    Hikma Pharmaceuticals PLC
15 September 2008

    NOTIFICATION OF TRANSACTION OF DIRECTOR/PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS
    This form is intended for use by an issuer to make a RIS notification required by DTR 3.1.4R(1).


    (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes
1 to 16, 23 
    and 24.

    (2) An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8,13,
14, 16, 23 and 24.

    (3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should
complete boxes 1 to 3 and 17 to 24.

    (4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture)
should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.



    Please complete all relevant boxes should in block capital letters.



    1. Name of the issuer

    HIKMA PHARMACEUTICALS PLC

    ....................................

    2. State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.4R(1)(a); or

    (ii) DTR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or

    (iii) both (i) and (ii)

    (iii)

    ....................................

    3. Name of person discharging managerial responsibilities/director

    DR RONALD GOODE

    ....................................

    4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3
and identify the connected person

    N/A

    ....................................

    5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a
non-beneficial interest

    3 ABOVE

    ....................................

    6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares

    ORDINARY SHARES OF 10 PENCE EACH

    ....................................

    7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

    Vidacos Nominees Limited

    ....................................

    8 State the nature of the transaction

    ACQUISTION OF SHARES 

    ....................................

    9. Number of shares, debentures or financial instruments relating to shares acquired

    3,000 ORDINARY SHARES

    ....................................

    10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

    0.0016%

    ....................................

    11. Number of shares, debentures or financial instruments relating to shares disposed

    N/A

    ....................................

    12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

    N/A

    ....................................

    13. Price per share or value of transaction

    433 PENCE PER SHARE

    ....................................

    14. Date and place of transaction

    4 SEPTEMBER 2008, UK

    ....................................

    15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken
into account when calculating percentage)

    9,000 (0.0047%)

    ....................................

    16. Date issuer informed of transaction

    12 SEPTEMBER 2008

    ....................................

    If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes


    17 Date of grant

    ....................................

    18. Period during which or date on which it can be exercised

    ....................................

    19. Total amount paid (if any) for grant of the option

    ....................................

    20. Description of shares or debentures involved (class and number)

    ....................................

    21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

    ....................................

    22. Total number of shares or debentures over which options held following notification

    ....................................

    23. Any additional information

    N/A

    ....................................

    24. Name of contact and telephone number for queries

    HENRY KNOWLES, COMPANY SECRETARY, 020 7399 2760 

    ....................................

    Name and signature of duly authorised officer of issuer responsible for making notification

    HENRY KNOWLES, COMPANY SECRETARY, 020 7399 2760

    ....................................

    Date of notification

    15 SEPTEMBER 2008

    ....................................

    END


This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
RDSBLGDCCBBGGIU
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Hikma Pharmaceuticals Charts.
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Hikma Pharmaceuticals Charts.